Anti-PDCD1 Therapeutic Antibody (Nivolumab)
Recombinant human monoclonal antibody expressed in CHO binding to human PDCD1. Nivolumab is a fully human IgG4 monoclonal antibody for the treatment of cancer. Nivolumab acts as an immunomodulator by blocking ligand activation of the programmed cell death 1 (PD-1) receptor on activated T cells.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-770 |
| Pricing | Inquiry |
| Host | Human |
| Target | PDCD1 |
| Species Reactivity | Human |
| Type | IgG4 - kappa |
| Applications | IF, IP, Neut, FuncS, ELISA, FC, ICC |
| Storage | Store it under sterile conditions at -20°C upon receiving. Recommend to pack the protein into smaller quantities for optimal storage. |